Type 1 Diabetes (update): appendices
Guide to appendices
Appendices Part 1:
- Appendix A: Scope
- Appendix B: Declarations of interest
- Appendix C: Review protocols
- Appendix D: Clinical article selection
- Appendix E: Economic article selection
- Appendix F: Literature search strategies
Appendices Part 2:
- Appendix G: Clinical evidence tables
Appendices Part 3:
- Appendix H: Economic evidence tables
- Appendix I: GRADE tables
- Appendix J: Forest plots
- Appendix K: Excluded clinical studies
- Appendix L: Excluded economic studies
- Appendix M: Network meta-analysis: long-acting insulin
- Appendix N: Cost-effectiveness analysis: Long-acting insulin and insulin regimen
- Appendix O: Cost-effectiveness analysis – HbA1c threshold
- Appendix P: Cost-effectiveness analysis – Continuous glucose monitoring (CGM) versus standard monitoring of blood glucose (SMBG)
- Appendix Q: Unit costs
- Appendix R: Research recommendations
- Appendix S: Removed text from CG15
- Appendix T: How this clinical guideline was updated
- Appendix U: NICE technical team
This page was last updated: 10 December 2014